logo

For the Inventor, By the Inventor

Birmingham, AL, United States of America

Steve E Ealick

This inventor holds 8 USPTO granted patents. Top assignees: Biocryst, Inc., Biocryst Pharmaceuticals, Inc.. Active years: 1991-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steve E Ealick. Retrieved from https://idiyas.com/inventor/steve-e-ealick

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 100.0

Average Co-Inventor Count = 4.9

ph-index = 5

Forward Citations = 96(Granted Patents)


Company Filing History:

goldMedal5 out of 5 
 
Biocryst, Inc.
 patents
silverMedal3 out of 92 
 
Biocryst Pharmaceuticals, Inc.
 patents

Years Active: 1991-1998

Loading Chart...
8 patents (USPTO):Explore Patents
1. 5726311 - 7-disubstituted-methyl-4-oxo-3H,5H-pyrrolo�3,2-d!pyrimidine and (1998-03-10),
2. 5721240 - 9-substituted-8-unsubstituted-9-deazaguanines (1998-02-24),
3. 5565463 - 9-subtituted-8-unsubstituted-9-deazaguanines (1996-10-15),
4. 5189039 - 7-disubstituted-methyl-4-oxo-3H,5H-pyrrolo[3,2d]pyrimidine and (1993-02-23),
5. 5008270 - 2-amino-7-(heterocyclomethyl)-3H,5H-pyrrolo[3,2-d]pyrimidin-4-ones and (1991-04-16),
6. 5008265 - 2-amino-7-(alicyclomethyl)-3H,5H,-pyrrolo[3,2-d]pyrimidin-4-ones and (1991-04-16),
7. 4985434 - 7-substituted derivatives of (1991-01-15),
8. 4985433 - 2-amino-7-(pyridinylmethyl)-3H,5H-pyrrolo[3,2-d]pyrimidin-4-ones and (1991-01-15),

Title: The Innovative Contributions of Steve E Ealick

Introduction

Steve E Ealick is a notable inventor based in Birmingham, AL (US). He has made significant contributions to the field of pharmaceuticals through his innovative inventions. With a total of 8 patents, Ealick has demonstrated a commitment to advancing scientific knowledge and technology.

Latest Patents

Among his latest patents, Ealick has developed compounds such as 7-disubstituted-methyl-4-oxo-3H,5H-pyrrolo[3,2-d]pyrimidine. This compound is characterized by a complex formula that includes various substituents, making it useful in pharmaceutical applications. Another notable patent is for 9-substituted-8-unsubstituted-9-deazaguanines, which also features a detailed chemical structure aimed at enhancing medicinal properties.

Career Highlights

Ealick has worked with prominent companies in the pharmaceutical industry, including Biocryst, Inc. and Biocryst Pharmaceuticals, Inc. His work in these organizations has allowed him to contribute to the development of innovative therapeutic solutions.

Collaborations

Some of his notable coworkers include John A Secrist, III and John A Montgomery. Their collaborative efforts have likely played a role in the success of Ealick's inventions.

Conclusion

Steve E Ealick's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…